Statement on Emergency Use Approval for Pfizer COVID-19 Vaccine
By Andy Brailo, Chief Customer Officer
Today’s announcement of the FDA’s emergency use approval for Pfizer’s COVID-19 vaccine is welcome news. The availability of vaccine doses in less than one year from COVID-19 onset in January of 2020 represents a remarkable scientific achievement and is a testament to American ingenuity and progress.
While a commercially available COVID-19 vaccine is an important milestone on the road to recovery, mass vaccination of the American people represents a monumental effort unlike any we’ve undertaken before. The distribution and administration of COVID-19 vaccines to the public will be the supply chain and population health challenge of the pandemic.
Enormous hurdles and questions remain on security, cold-chain capability and supplies, and equitable access and distribution in rural and diverse communities. Alongside these added complexities, many of Premier’s members have been designated a hub, tasked with distribution to other vaccination facilities within their states.
As we move forward to vaccinate large portions of our population, Premier remains committed to sharing education, best practices and solutions ─ while working closely with our members to help ensure this vital effort runs as smoothly as possible. Our members, and the healthcare community, stand ready to rise to meet this monumental challenge.
About Premier, Inc.
Premier, Inc. (NASDAQ: PINC) is a leading technology-driven healthcare improvement company, providing solutions to two-thirds of all healthcare providers in the U.S. Playing a critical role in the rapidly evolving healthcare industry, Premier unites providers, suppliers, payers and policymakers to make healthcare better with national scale, smarter with actionable intelligence and faster with novel technologies. Headquartered in Charlotte, N.C., Premier offers integrated data and analytics, collaboratives, supply chain solutions, consulting and other services in service of our mission to improve the health of communities. Please visit Premier’s news and investor sites on www.premierinc.com; as well as X, Facebook, LinkedIn, YouTube, Instagram and Premier’s blog for more information about the company.